Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Green Tea Extract BP EP USP Pharma Grade refers to a high-purity, standardized extract derived from the leaves of Camellia sinensis, compliant with international pharmacopeial standards—British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP). Formulators and researchers utilize this ingredient across health, wellness, and pharmaceutical applications for its polyphenol content, especially epigallocatechin gallate (EGCG), catechins, and other bioactive molecules.
The extract appears as a light to dark green powder with a fine, free-flowing texture. Consistency remains one of its prominent features, as the powder resists caking and disperses easily in solution for analytical purposes. Although some manufacturers offer flakes or granules, the dominant and preferred form for pharmaceutical use remains the fine powder, optimized for homogenous blending in formulations.
Strong antioxidant odor and astringent taste signal the presence of potent phytonutrients. Moisture content typically registers below 5%, safeguarding shelf stability. Bulk density varies, often between 0.40 and 0.60 g/cm³, allowing accurate dosing and reliable batch-to-batch handling. Solubility characteristics highlight partial dispersibility in cold water, with higher solubility in ethanol or warm water, matching extraction and formulation requirements. Product stability improves with tightly sealed containers, protected from light, air, and humidity. Under these conditions, degradation of polyphenols remains minimal within the first year.
Green Tea Extract's molecular complexity arises from a mixture of catechins. EGCG, with the molecular formula C22H18O11 and molar mass of 458.37 g/mol, dominates the polyphenolic profile. Other catechins—epicatechin (EC, C15H14O6) and epicatechin gallate (ECG, C22H18O10)—also contribute. This intricate polyphenol matrix defines the extract's antioxidant and anti-inflammatory activity. Laboratories employ advanced methods such as HPLC to quantify specific components, ensuring compliance with monographs and safety benchmarks.
Standardized grades often contain polyphenols ranging from 45% to above 90%, with EGCG alone sometimes exceeding 30% of the entire extract. Ash content sits beneath 3%, and heavy metal contamination must not surpass pharmacopeial thresholds—pharmaceutical-grade lots test rigorously for pesticide residues, aflatoxins, and microbial contaminants. Typically, loss on drying scores under 5%. HS Code 1302.19 classifies plant extracts such as green tea extract for customs and regulatory identification throughout international supply chains.
The powder form dominates for pharma use, supporting easy weighing, dispersion, and encapsulation. Some batches come pressed into flakes or pearls, especially where precise, slow-release blending becomes necessary. Solid blocks are rare in the pharma context, and liquid preparations frequently result from suspensions designed for direct oral dosage. Crystalline green tea extract does not appear due to the natural variability of plant sources and the multitude of active molecules, but small crystalline material might appear in high-purity EGCG isolates. Each prepared form matches its own storage and shelf life profile, reflecting the intended application—capsules, tablets, drinks, topical solutions, and raw materials for further transformation.
Powdered extract's specific gravity impacts handling and formulation. In my experience working alongside formulation chemists, bulk density inconsistencies can complicate lengthy scaling efforts, emphasizing the importance of purchasing from reputable, pharmacopeia-compliant suppliers. Regarding solutions, blending green tea extract into liquid matrices such as syrups or suspensions requires surfactant compatibility and attention to pH, since catechins degrade in highly alkaline or acidic environments. Material handling procedures stress the need for dust masks and gloves, not because of acute toxicity, but to minimize inhalation and skin exposure to concentrated phytochemicals and residual solvents.
Manufacturers flag green tea extract as a raw material with generally recognized safety for most applications, but concentrated bulk powders demand careful risk management. Acute toxicity rarely presents in standard pharmaceutical use. The bigger concern revolves around chronic, large-dose exposure linked epidemiologically to liver enzyme alteration, which underscores the wisdom of dosage limits. Combustibility represents a low but not negligible hazard in bulk storage, similar to most fine organic powders. Eye or respiratory irritation can arise in poorly ventilated spaces, driving SOPs towards proper PPE and air filtration. Regulatory documentation—MSDS sheets—advise response tactics for accidental ingestion, eye exposure, and fire control, mostly involving water mist and CO₂ extinguishers. In my own lab years, mishandling was uncommon, but accidental spills certainly reminded all present of the need for good housekeeping and prompt clean-up routines. Green tea extract neither presents the acute chemical risks seen in volatile solvents, nor the type of persistent, cumulative harm of classic toxins, but respectful handling protects both product quality and worker health.
Pharma-grade green tea extract fits into capsules, tablets, and functional foods as a source of natural antioxidants, favored by manufacturers aiming for both regulatory compliance and broad market appeal. Its efficacy for metabolic health, anti-inflammatory effects, and cell protection finds direct support in multiple peer-reviewed studies. As with many plant-sourced actives, the importance of well-defined, tightly controlled raw materials stands out. The supply chain can make or break a product’s safety and therapeutic effect—scrupulous sourcing, validated analytical certificates, and transparent traceability not only fulfill legal and market requirements, but they build factual trust with practitioners, formulators, and every downstream end-user.
Chengguan District, Lanzhou, Gansu, China
